Drug Information

Drug General Information
Drug ID
D0O2GK
Former ID
DNC008528
Drug Name
N-(2-(5-methoxybenzofuran-3-yl)ethyl)acetamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529396]
Formula
C13H15NO3
Canonical SMILES
CC(=O)NCCC1=COC2=C1C=C(C=C2)OC
InChI
1S/C13H15NO3/c1-9(15)14-6-5-10-8-17-13-4-3-11(16-2)7-12(10)13/h3-4,7-8H,5-6H2,1-2H3,(H,14,15)
InChIKey
BTVRPXLAXZPZPV-UHFFFAOYSA-N
PubChem Compound ID
10059864
Target and Pathway
Target(s) Melatonin receptor type 1B Target Info Inhibitor [529396]
Melatonin receptor Target Info Inhibitor [529396]
KEGG Pathway Neuroactive ligand-receptor interaction
Circadian entrainmenthsa04080:Neuroactive ligand-receptor interaction
Circadian entrainment
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling eventsR-HSA-373076:Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
GPCR downstream signaling
References
Ref 529396Bioorg Med Chem. 2008 May 1;16(9):4954-62. Epub 2008 Mar 17.Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.
Ref 529396Bioorg Med Chem. 2008 May 1;16(9):4954-62. Epub 2008 Mar 17.Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.